Rejected at 4:06 a.m. Nov, 01, 2023 ] by Ahmed7
Author: mmccracken4
Related Note: 1485037302273
Rationale for change

Adding the info that cyproheptadine is only used if the patient's sxs are refractory to the initial supportive measures and sedation with a benzo (see UWorld explination of this question)
Source: UWorld - Step 2 20355

Rejection reason

response time rejection

Text Text
Extra
- Also shown to antagonize H1 and 5-HT1A receptors

- Prior to use of cyproheptadine, attempt supportive measures (hydration, cooling, and BP control) and sedation with benzodiazepine

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch SSRIs, SNRIs, Cyproheptadine
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

Bootcamp
Watch associated Bootcamp video - Psychiatric Emergencies
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step2_v12::#AMBOSS::t70Xnh #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step2_v12::#AMBOSS::jSa_zP #AK_Step2_v12::Original_decks::Dorian::neuro::amboss #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::40_Psychiatric_emergencies::*Serotonin_Syndrome::Treatment #AK_Step2_v12::!Shelf::Neuro::no_dupes #AK_Step1_v12::#UWorld::Step::2089 #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #AK_Step2_v12::#AMBOSS::CZaqdQ #AK_Step2_v12::#Resources_by_rotation::Neuro::amboss #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::01_Antidepressants::Extra #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::16_Psychiatric_Emergencies #PANCE::EOR::PSYCH #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#UWorld::COMLEX::104693 #PANCE::BEHAVIORAL::depression #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step1_v12::#B&B::15_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters::Extra #AK_Step2_v12::#OME::04_Psychiatry::11_Catatonia #AK_Step2_v12::#UWorld::Step::20355 #AK_Step1_v12::#UWorld::COMLEX::25198 #AK_Step1_v12::#AMBOSS::CZaqdQ #AK_Step1_v12::^Systems::Neuro::Pharmacology !AK_UpdateTags::AnKing_Image::AhmedA #AK_Step1_v12::#AMBOSS::jSa_zP #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#OME::Clinical::Psychiatry::Personality_and_Psychosis::Catatonia #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::01_Serotonin_Syndrome